Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KRRO Korro Bio, Inc.

盘前交易 01-12 05:32:15 EST

9.50

+0.35

+3.83%

最高9.59	最低9.06	成交量26.53万
今开9.23	昨收9.15	日振幅5.74%
总市值8,946万	流通市值5,457万	总股本941.73万
成交额250.11万	换手率4.62%	流通股本574.40万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":9.5,"timestamp":1767992400000,"preClose":9.15,"halted":0,"volume":265322,"delay":0,"floatShares":5744014,"shares":9417295,"eps":-9.422738,"marketStatus":"盘前交易","change":0.35,"latestTime":"01-12 05:32:15 EST","open":9.23,"high":9.585,"low":9.06,"amount":2501053.057204,"amplitude":0.057377,"askPrice":11.91,"askSize":100,"bidPrice":9.3,"bidSize":37,"shortable":3,"etf":0,"ttmEps":-9.422738,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768228200000},"marketStatusCode":1,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":9.5,"postHourTrading":{"tag":"盘后","latestPrice":9.28,"preClose":9.5,"latestTime":"19:50 EST","volume":1483,"amount":14085.222,"timestamp":1768006214121},"volumeRatio":1.33471975825218,"impliedVol":0.9851,"impliedVolPercentile":0.3036},"requestUrl":"/m/hq/s/KRRO","defaultTab":"news","newsList":[{"id":"2586745440","title":"Korro Bio, Inc.盘中异动 临近午盘快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586745440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586745440?lang=zh_cn&edition=full","pubTime":"2025-11-25 00:50","pubTimestamp":1764003015,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日00时50分，Korro Bio, Inc.股票出现异动，股价大幅下跌5.10%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125005015a70eb9af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125005015a70eb9af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583500324","title":"Korro Bio, Inc.盘中异动 早盘大幅下挫5.38%报6.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583500324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583500324?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:04","pubTimestamp":1763132679,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时04分，Korro Bio, Inc.股票出现波动，股价大幅下挫5.38%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142304409504bd59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142304409504bd59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583742005","title":"Korro Bio的RNA编辑药物例临床结果不佳，引发裁员，诺和诺德暂停合作 | 2025Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2583742005","media":"Minhua笔记","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583742005?lang=zh_cn&edition=full","pubTime":"2025-11-14 18:13","pubTimestamp":1763115231,"startTime":"0","endTime":"0","summary":"诺和诺德与Korro的合作协议暂停一年，用于重新评估伙伴关系。公告后，Korro Bio股价暴跌近80%，市值大幅缩水；多家投行下调评级。11月13日，Korro Bio公布了其最新财务业绩，同时披露了重大临床挫折。报道指出，作为应对措施，Korro Bio宣布进行公司重组，包括裁减约34%的员工。此次事件导致Korro Bio股价在11月13日开盘后暴跌近80%，从前一交易日收盘价大幅下滑。当天，Korro宣布第三季度末现金流为1.025亿美元，并计划通过裁员约34%来延长现金储备至2027年下半年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114181901a6f94906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114181901a6f94906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4532","BK4505","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD","BK4139","BK4599","IE0009354923.USD","LU1093756325.SGD","LU1093756168.USD","NVO","LU0154236417.USD","BK4007","BK4585","RNA"],"gpt_icon":1},{"id":"1101628641","title":"Korro Bio 股价在盘前下跌78.5%，因实验药物 Krro-110 试验失败，暂停与诺和诺德的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1101628641","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101628641?lang=zh_cn&edition=full","pubTime":"2025-11-13 19:37","pubTimestamp":1763033832,"startTime":"0","endTime":"0","summary":"Korro Bio 股价在盘前下跌78.5%，因为其实验药物 Krro-110 在试验中宣布失败，并暂停了与诺和诺德的交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"1141108719","title":"Korro Bio与诺和诺德达成协议，补偿Korro持有期相关的部分清算费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1141108719","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141108719?lang=zh_cn&edition=full","pubTime":"2025-11-13 06:24","pubTimestamp":1762986281,"startTime":"0","endTime":"0","summary":"Korro Bio与诺和诺德达成协议，补偿Korro持有期相关的部分清算费用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"1185362886","title":"Korro Bio, Inc. 同意结束与许可协议相关的研发活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1185362886","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185362886?lang=zh_cn&edition=full","pubTime":"2025-11-13 06:24","pubTimestamp":1762986271,"startTime":"0","endTime":"0","summary":"Korro Bio, Inc. 同意结束与许可协议相关的研发活动","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2577584291","title":"Korro Bio, Inc.盘中异动 早盘大幅上涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577584291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577584291?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:36","pubTimestamp":1761226606,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时36分，Korro Bio, Inc.股票出现异动，股价大幅拉升5.70%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213646973ea7f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213646973ea7f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2576863061","title":"Korro Bio, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576863061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576863061?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:46","pubTimestamp":1760967991,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时46分，Korro Bio, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报44.29美元/股，成交量7926股，换手率0.08%，振幅1.64%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510202146319738cf63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510202146319738cf63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"1142561583","title":"Korro Bio任命Ram Aiyar为临时首席财务官兼主要财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1142561583","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142561583?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:35","pubTimestamp":1759923329,"startTime":"0","endTime":"0","summary":"Korro Bio宣布任命Ram Aiyar担任公司临时首席财务官兼主要财务官职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"1101198813","title":"Korro Bio：首席财务官Vineet Agarwal宣布将于2025年10月17日辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=1101198813","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101198813?lang=zh_cn&edition=full","pubTime":"2025-10-08 19:35","pubTimestamp":1759923303,"startTime":"0","endTime":"0","summary":"Korro Bio宣布，首席财务官Vineet Agarwal已表达辞职意向，辞职将于2025年10月17日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2572598345","title":"Korro Bio, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572598345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572598345?lang=zh_cn&edition=full","pubTime":"2025-10-02 00:23","pubTimestamp":1759335791,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日00时23分，Korro Bio, Inc.股票出现波动，股价急速下挫5.03%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.87%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100200231294b76a86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100200231294b76a86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2572373296","title":"Korro Bio, Inc.盘中异动 早盘大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572373296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572373296?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:01","pubTimestamp":1759240903,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时01分，Korro Bio, Inc.股票出现异动，股价大幅上涨5.08%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220143a44eb601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220143a44eb601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2566648080","title":"Korro Bio, Inc.盘中异动 临近午盘大幅上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566648080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566648080?lang=zh_cn&edition=full","pubTime":"2025-09-09 23:37","pubTimestamp":1757432275,"startTime":"0","endTime":"0","summary":"北京时间2025年09月09日23时37分，Korro Bio, Inc.股票出现波动，股价快速上涨5.36%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909233756a4bec6c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909233756a4bec6c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2562874837","title":"Korro Bio, Inc.盘中异动 早盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562874837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562874837?lang=zh_cn&edition=full","pubTime":"2025-08-25 22:39","pubTimestamp":1756132764,"startTime":"0","endTime":"0","summary":"北京时间2025年08月25日22时39分，Korro Bio, Inc.股票出现波动，股价大幅上涨5.19%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082522392494fba886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082522392494fba886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2558664691","title":"Korro Bio, Inc.盘中异动 急速下跌5.19%报15.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664691?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:18","pubTimestamp":1754929110,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日00时18分，Korro Bio, Inc.股票出现波动，股价大幅下跌5.19%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120018319741228c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120018319741228c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2557520170","title":"Korro Bio, Inc.盘中异动 早盘大幅拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520170?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:54","pubTimestamp":1754661266,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时54分，Korro Bio, Inc.股票出现波动，股价快速上涨5.67%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215427a47d6430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215427a47d6430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2557833879","title":"Korro Bio, Inc.盘中异动 大幅拉升6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557833879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557833879?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:55","pubTimestamp":1754322950,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时55分，Korro Bio, Inc.股票出现异动，股价快速上涨6.38%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423555094cf287a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423555094cf287a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2556837767","title":"Korro Bio, Inc.盘中异动 下午盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556837767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556837767?lang=zh_cn&edition=full","pubTime":"2025-08-01 01:09","pubTimestamp":1753981764,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日01时09分，Korro Bio, Inc.股票出现异动，股价急速下跌5.41%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.78%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080101092594c6c441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080101092594c6c441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2555042091","title":"Korro Bio, Inc.盘中异动 股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555042091?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:34","pubTimestamp":1753882474,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时34分，Korro Bio, Inc.股票出现波动，股价急速拉升5.80%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302134349727df02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302134349727df02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2555970540","title":"Korro Bio, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555970540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555970540?lang=zh_cn&edition=full","pubTime":"2025-07-29 02:20","pubTimestamp":1753726843,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日02时20分，Korro Bio, Inc.股票出现波动，股价急速下挫5.00%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729022043a468249e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729022043a468249e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.korrobio.com","stockEarnings":[{"period":"1week","weight":0.1801},{"period":"1month","weight":0.2133},{"period":"3month","weight":-0.7789},{"period":"6month","weight":-0.2526},{"period":"1year","weight":-0.7475},{"period":"ytd","weight":0.186}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Korro Bio, Inc.于2014年11月13日在特拉华州的一家公司注册成立。该公司是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，从而能够治疗罕见和高度流行的疾病。该公司正在生成一个差异化程序组合，这些程序旨在利用人体的自然RNA编辑过程来实现精确但短暂的单碱基编辑。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.119727},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.244664},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.156784},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.137999},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.130881},{"month":6,"riseRate":0.666667,"avgChangeRate":0.076651},{"month":7,"riseRate":0.666667,"avgChangeRate":0.188038},{"month":8,"riseRate":0.5,"avgChangeRate":0.063109},{"month":9,"riseRate":0.166667,"avgChangeRate":0.053807},{"month":10,"riseRate":0.333333,"avgChangeRate":0.036402},{"month":11,"riseRate":0.571429,"avgChangeRate":0.300569},{"month":12,"riseRate":0.857143,"avgChangeRate":0.185509}],"exchange":"NASDAQ","name":"Korro Bio, Inc.","nameEN":"Korro Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Korro Bio, Inc.,KRRO,Korro Bio, Inc.股票,Korro Bio, Inc.股票老虎,Korro Bio, Inc.股票老虎国际,Korro Bio, Inc.行情,Korro Bio, Inc.股票行情,Korro Bio, Inc.股价,Korro Bio, Inc.股市,Korro Bio, Inc.股票价格,Korro Bio, Inc.股票交易,Korro Bio, Inc.股票购买,Korro Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}